Acuta Capital Partners’s Larimar Therapeutics LRMR Stock Holding History

Acuta Capital Partners’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-863,100	Closed	-$18.5M	–	53
2020 Q4	$18.5M	Buy	863,100 +33,100	+4%	+$663K	5.09%	4
2020 Q3	$12.6M	Buy	830,000 +6,831	+0.8%	+$86.5K	3.7%	7
2020 Q2	$10.3M	Buy	823,169 +707,669	+613%	+$8.24M	2.97%	11
2020 Q1	$1.07M	Buy	115,500 +32,167	+39%	+$423K	0.52%	29
2019 Q4	$1.11M	Buy	+83,333	New	+$796K	0.32%	37
2018 Q3	–	Sell	-20,833	Closed	-$2.56M	–	46
2018 Q2	$2.56M	Buy	+20,833	New	+$1.77M	0.5%	35
2015 Q4	–	Sell	-4,293	Closed	-$1.65M	–	67
2015 Q3	$1.65M	Sell	4,293 -115	-3%	-$51.8K	1.04%	35
2015 Q2	$1.83M	Sell	4,408 -3,925	-47%	-$1.64M	1.2%	27
2015 Q1	$3.96M	Sell	8,333 -22	-0.3%	-$10.4K	3.55%	8
2014 Q4	$3.09M	Buy	+8,355	New	+$2.15M	3.04%	10

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return